Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 8 Endometrial Hyperplasia 4 Overweight 2 Obesity 2 Neoplasms 2 Weight Loss 1 Menorrhagia 1 Leiomyoma 1 Infertility 1 Hematologic Neoplasms 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Breast Neoplasms 1 Breast Cancer Patients Treated With T-DXd 1 Anorexia 1

Interventions

anamorelin 2 Caloric Restriction 2 Urine Specimen Collection 1 Tirzepatide 1 Sampling Studies 1 Resistance Training 1 Psychology, Positive 1 Population Groups 1 Olanzapine 1 Nutrition Assessment 1 Mirtazapine 1 Methods 1 Metformin 1 Megestrol Acetate 1 Inositol 1 Growth Differentiation Factor 15 1 Diet, Reducing 1 Diet Therapy 1 Diet 1 Counseling 1 Cognitive Behavioral Therapy 1 Breast Implants 1 Blood Specimen Collection 1 Biopsy 1 2,2,2',4'-tetrachloroacetophenone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Weight Loss × Megestrol Acetate × 1 year × Clear all

NCT06998758 2025-12-12

MATRIX

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 3 Recruiting

Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡